Skip to main navigation Skip to search Skip to main content

An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease

Project: Research

Project Details

StatusActive
Effective start/end date07/22/2505/21/26

Funding

  • United Therapeutics Corporation: $17,083.00